学校法人順天堂　研究者情報データベース:::研究業績詳細:::

HOME　＞　研究業績詳細

研究業績詳細

井尾浩章（イオヒロアキ）

研究テーマ	腎臓内科
研究業績（論文）	英文原著 1. Zheng YL, Liao J, Takeda Y, Io H, Kobata M, Kanamaru Y, Maeda A, Shou I,Igari J, Tomino Y. Determination of sensitivity and specificity of the Micral-Test II strip for detection of microalbuminuria in diabetic and nondiabetic patients. Nephron. 1999;81(4):455. PubMed PMID: 10095190., IF 2.085 (SCIE, CC, ESCI), CI=2 2. Kubota M, Kanazawa M, Takahashi Y, Io H, Ishiguro N, Tomino Y. Implantation of presternal catheter using Moncrief technique: aiming for fewer catheter-related complications. Perit Dial Int. 2001;21 Suppl 3:S205-8. PubMed PMID: 11887822., IF 1.934 (SCIE, CC, ESCI), CI=10 3. Io H, Takeda Y, Okumura K, Sakamoto N, Obayashi K, Suzuki S, Funabiki K, Horikoshi S, Shirato I, Tomino Y. [A case of gastric antral vascular ectasia (GAVE) with chronic renal failure]. Nihon Jinzo Gakkai Shi. 2001;43(2):82-7. Review. Japanese. PubMed PMID: 11280215., IF NA (NA), N=NA 4. Shimizu-Tokiwa A, Kobata M, Io H, Kobayashi N, Shou I, Funabiki K, Fukui M, Horikoshi S, Shirato I, Saito K, Tomino Y. Serum cystatin C is a more sensitive marker of glomerular function than serum creatinine. Nephron. 2002 Sep;92(1):224-6. PubMed PMID: 12187109., IF 2.085 (SCIE, CC, ESCI), CI=35 5. Io H, Hamada C, Ro Y, Ito Y, Hirahara I, Tomino Y. Morphologic changes of peritoneum and expression of VEGF in encapsulated peritoneal sclerosis rat models. Kidney Int. 2004 May;65(5):1927-36. PubMed PMID: 15086936., IF 8.306 (SCIE, CC, ESCI), CI=77 6. Io H, Hamada C, Fukui M, Horikoshi S, Tomino Y. Relationship between levels of urinary type IV collagen and renal injuries in patients with IgA nephropathy. J Clin Lab Anal. 2004;18(1):14-8. PubMed PMID: 14730552; PubMed Central PMCID: PMC6807931., IF 1.728 (SCIE, CC, ESCI), CI=10 7. Ro Y, Hamada C, Io H, Hayashi K, Hirahara I, Tomino Y. Rapid, simple, and reliable method for the diagnosis of CAPD peritonitis using the new MMP-9 test kit. J Clin Lab Anal. 2004;18(4):224-30. PubMed PMID: 15202114; PubMed Central PMCID: PMC6807828., IF 1.728 (SCIE, CC, ESCI), CI=11 8. Hamada C, Hayashi K, Shou I, Inaba M, Ro Y, Io H, Maeda K, Fukui M, Tomino Y. Pharmacokinetics of calcitriol and maxacalcitol administered into peritoneal dialysate bags in peritoneal dialysis patients. Perit Dial Int. 2005 Nov-Dec;25(6):570-5. PubMed PMID: 16411524. IF 1.934 (SCIE, CC, ESCI), CI=3 9. Ro Y, Hamada C, Inaba M, Io H, Kaneko K, Tomino Y. Inhibitory effects of matrix metalloproteinase inhibitor ONO-4817 on morphological alterations in chlorhexidine gluconate-induced peritoneal sclerosis rats. Nephrol Dial Transplant. 2007 Oct;22(10):2838-48. Epub 2007 Jun 2. PubMed PMID: 17545675., IF 4.198 (SCIE, CC, ESCI), CI=34 10. Inoshita H, Gohda T, Io H, Kaneko K, Hamada C, Horikoshi S, Tomino Y. Improvement of peritoneal calcification after parathyroidectomy in a peritoneal dialysis patient. Clin Nephrol. 2008 Jan;69(1):58-62. PubMed PMID: 18218318., IF 1.079 (SCIE, CC, ESCI), CI=8 11. Gohda T, Gotoh H, Tanimoto M, Sato M, Io H, Kaneko K, Hamada C, Tomino Y. Relationship between abdominal fat accumulation and insulin resistance in hemodialysis patients. Hypertens Res. 2008 Jan;31(1):83-8. doi: 10.1291/hypres.31.83. PubMed PMID: 18360022., IF 3.217 (SCIE, CC, ESCI), CI=31 12. Hotta Y, Kaneko K, Inuma J, Inami Y, Aruga S, Shimaoka T, Sekiguchi Y, Io H, Hamada C, Obinata M, Ueda M, Tomino Y. Establishment of a peritoneal mesothelial cell line from a transgenic rat harbouring the temperature-sensitive simian virus 40 large T-antigen gene. Nephrol Dial Transplant. 2010 Jun;25(6):1825-32. doi: 10.1093/ndt/gfp742. Epub 2010 Jan 18. PubMed PMID: 20083474., IF 4.198 (SCIE, CC, ESCI), CI=5 13. Io H, Ro Y, Sekiguchi Y, Shimaoka T, Inuma J, Hotta Y, Aruga S, Inami Y, Sat M, Kobayashi T, Masuda A, Kaneko K, Hamada C, Ohtaki E, Horikoshi S, Tomino Y. Cardiac function and structure in longitudinal analysis of echocardiography in peritoneal dialysis patients. Perit Dial Int. 2010 May-Jun;30(3):353-61. doi: 10.3747/pdi.2009.00007. Epub 2010 Mar 25. PubMed PMID: 20338970., IF 1.934 (SCIE, CC, ESCI), CI=10 14. Shimaoka T, Hamada C, Kaneko K, Io H, Sekiguchi Y, Aruga S, Inuma J, Inami Y, Hotta Y, Horikoshi S, Kumasaka T, Tomino Y. Quantitative evaluation and assessment of peritoneal morphologic changes in peritoneal dialysis patients. Nephrol Dial Transplant. 2010 Oct;25(10):3379-85. doi: 10.1093/ndt/gfq194. Epub 2010 Apr 22. PubMed PMID: 20466666., IF 4.198 (SCIE, CC, ESCI), CI=20 15. Furukawa M, Io H, Tanimoto M, Hagiwara S, Horikoshi S, Tomino Y. Predictive factors associated with the period of time before initiation of hemodialysis in CKD stages 4 and 5. Nephron Clin Pract. 2011;117(4):c341-7. doi: 10.1159/000321512. Epub 2010 Oct 15. PubMed PMID: 20948232., IF 2.085 (SCIE, CC, ESCI), CI=12 16. Io H, Matsumoto M, Okumura K, Sato M, Masuda A, Furukawa M, Nohara N, Tanimoto M, Kodama F, Hagiwara S, Gohda T, Shimizu Y, Tomino Y. Predictive factors associated with left ventricular hypertrophy at baseline and in the follow-up period in non-diabetic hemodialysis patients. Semin Dial. 2011 May-Jun;24(3):349-54. doi: 10.1111/j.1525-139X.2010.00759.x. Epub 2010 Aug 13. PubMed PMID: 20723158., IF 2.056 (SCIE, CC, ESCI), CI=12 17. Tomino Y, Shimizu Y, Hamada C, Kurusu A, Ohsawa I, Suzuki Y, Tsuge T, Io H, Kobayashi N, Takeda Y, Asanuma K, Tanaka Y, Suzuki H, Nakata J, Takara K, Horikoshi S. One-year results of an open-label study on antiproteinuric effect of benidipine in elderly patients with chronic kidney disease. J Nephrol. 2011 Nov-Dec;24(6):756-63. doi: 10.5301/JN.2011.6383. PubMed PMID: 21360472., IF 3.698 (SCIE, CC, ESCI), CI=7 18. Inami Y, Yamaji K, Sato M, Gohda T, Io H, Nawata M, Hamada C, Takasaki Y, Tomino Y. Effects of dialysis on the pharmacokinetics of salazosulfapyridine. Rheumatol Int. 2013 Feb;33(2):535-9. doi: 10.1007/s00296-011-2179-1. Epub 2011 Nov 12. PubMed PMID: 22080212., IF 2.200 (SCIE, CC, ESCI), CI=3 19. Sato M, Io H, Tanimoto M, Shimizu Y, Fukui M, Hamada C, Horikoshi S, Tomino Y. Relationship between preoperative radial artery and postoperative arteriovenous fistula blood flow in hemodialysis patients. J Nephrol. 2012 Sep-Oct;25(5):726-31. doi: 10.5301/jn.5000050. PubMed PMID: 22081294., IF 3.698 (SCIE, CC, ESCI), CI=6 20. Masuda A, Hagiwara S, Tanimoto M, Kodama F, Okumura K, Nohara N, Matsumoto M, Maiguma M, Omote K, Io H, Kurusu A, Ohsawa I, Shimizu Y, Hamada C, Horikoshi S, Tomino Y. Effects of acetate-free citrate dialysate on glycoxidation and lipid peroxidation products in hemodialysis patients. Nephron Extra. 2012 Sep 27;2(1):256-68. doi: 10.1159/000342258. Print 2012 Jan. PubMed PMID: 23599704; PubMed Central PMCID: PMC3567873., IF NA (ESCI), CI=6 21. Matsumoto M, Io H, Furukawa M, Okumura K, Masuda A, Seto T, Takagi M, Sato M, Nagahama L, Omote K, Hisada A, Horikoshi S, Tomino Y. Risk factors associated with increased left ventricular mass index in chronic kidney disease patients evaluated using echocardiography. J Nephrol. 2012 Sep-Oct;25(5):794-801. doi: 10.5301/jn.5000066. PubMed PMID: 22241636., IF 3.698 (SCIE, CC, ESCI), CI=24 22. Sekiguchi Y, Hamada C, Ro Y, Nakamoto H, Inaba M, Shimaoka T, Io H, Koyanagi I, Aruga S, Inuma J, Kaneko K, Hotta Y, Margetts PJ, Mochizuki H, Horikoshi S, Tomino Y. Differentiation of bone marrow-derived cells into regenerated mesothelial cells in peritoneal remodeling using a peritoneal fibrosis mouse model. J Artif Organs. 2012 Sep;15(3):272-82. doi: 10.1007/s10047-012-0648-2. Epub 2012 May 24. PubMed PMID: 22622710., IF 1.519 (SCIE, CC, ESCI), CI=14 23. Iida H, Hasegawa T, Okuma K, Io H, Tomino Y, Ikeda S. Successfully maintained hemodialysis for the treatment of chronic renal failure in a patient with Hallopeau-Siemens type recessive dystrophic epidermolysis bullosa. J Dermatol. 2012 Dec;39(12):1088-9. doi: 10.1111/j.1346-8138.2012.01617.x. Epub 2012 Jun 23. PubMed PMID: 22725264., IF 3.377 (SCIE, CC, ESCI), CI=1 24. Kanda R, Hamada C, Kaneko K, Nakano T, Wakabayashi K, Io H, Horikoshi S, Tomino Y. Pentraxin 3 as a new biomarker of peritoneal injury in peritoneal dialysis patients. J Artif Organs. 2013 Mar;16(1):66-73. doi: 10.1007/s10047-012-0663-3. Epub 2012 Sep 27. PubMed PMID: 23010754., IF 1.519 (SCIE, CC, ESCI), CI=7 25. Okumura K, Io H, Matsumoto M, Seto T, Takagi M, Masuda A, Furukawa M, Nagahama L, Omote K, Hisada A, Hamada C, Horikoshi S, Tomino Y. Predictive factors associated with change rates of LV hypertrophy and renal dysfunction in CKD patients. Clin Nephrol. 2013 Jan;79(1):7-14. doi: 10.5414/CN107569. PubMed PMID: 23036229., IF 1.079 (SCIE, CC, ESCI), CI=12 26. Sasaki Y, Shimizu Y, Nakata J, Kameda T, Muto M, Ohsawa I, Io H, Hamada C, Horikoshi S, Tomino Y. Thyroid storm masked by hemodialysis and glucocorticoid therapy in a patient with rheumatoid arthritis. Case Rep Nephrol Urol. 2012 Jan;2(1):6-10. doi: 10.1159/000336624. Epub 2012 Feb 16. PubMed PMID: 23197948; PubMed Central PMCID: PMC3482076., IF NA (NA), CI=0 27. Shimizu Y, Ishii A, Takahata A, Kajiyama T, Yamahatsu A, Io H, Kurusu A, Hamada C, Horikoshi S, Tomino Y. Campylobacter bacteremia in hemodialysis patients by eating raw meat - the importance of sanitary education. Case Rep Nephrol Urol. 2012 Jul;2(2):145-51. doi: 10.1159/000343499. Epub 2012 Oct 24. PubMed PMID: 23197970; PubMed Central PMCID: PMC3507274., IF NA (NA), CI=6 28. Kanda R, Hamada C, Kaneko K, Nakano T, Wakabayashi K, Hara K, Io H, Horikoshi S, Tomino Y. Paracrine effects of transplanted mesothelial cells isolated from temperature-sensitive SV40 large T-antigen gene transgenic rats during peritoneal repair. Nephrol Dial Transplant. 2014 Feb;29(2):289-300. doi: 10.1093/ndt/gft397. Epub 2013 Sep 29. PubMed PMID: 24081857; PubMed Central PMCID: PMC3910341., IF 4.198 (SCIE, CC, ESCI), CI=7 29. Nakamoto H, Hamada C, Shimaoka T, Sekiguchi Y, Io H, Kaneko K, Horikoshi S, Tomino Y. Accumulation of advanced glycation end products and beta 2-microglobulin in fibrotic thickening of the peritoneum in long-term peritoneal dialysis patients. J Artif Organs. 2014 Mar;17(1):60-8. doi: 10.1007/s10047-013-0741-1. Epub 2013 Dec 14. PubMed PMID: 24337623., IF 1.519 (SCIE, ESCI), CI=8 30. Inami Y, Hamada C, Seto T, Hotta Y, Aruga S, Inuma J, Azuma K, Io H, Kaneko K, Watada H, Tomino Y. Effect of AST-120 on Endothelial Dysfunction in Adenine-Induced Uremic Rats. Int J Nephrol. 2014;2014:164125. doi:10.1155/2014/164125. Epub 2014 Apr 14. PubMed PMID: 24829798; PubMed Central PMCID: PMC4009319. IF NA (SCIE), CI=15 31. Io H, Maeda K, Sekiguchi Y, Shimaoka T, Aruga S, Nakata J, Nakamoto H, Hotta Y, Koyanagi I, Inaba M, Kanda R, Nakano T, Wakabayashi K, Sasaki Y, Inuma J, Kaneko K, Hamada C, Fukui M, Tomino Y. Comparison between the fixation of peritoneal dialysis catheters to the peritoneal wall and the conventional placement technique: clinical experience and follow-up of a new implant technique for peritoneal dialysis catheters. Semin Dial. 2014 Jul-Aug;27(4):E42-7. doi: 10.1111/sdi.12165. Epub 2013 Nov 22. PubMed PMID: 24262039., IF 2.056 (SCIE, CC, ESCI), CI=1 32. Wakabayashi K, Hamada C, Kanda R, Nakano T, Io H, Horikoshi S, Tomino Y. Adipose-derived mesenchymal stem cells transplantation facilitate experimental peritoneal fibrosis repair by suppressing epithelial-mesenchymal transition. J Nephrol. 2014 Oct;27(5):507-14. doi: 10.1007/s40620-014-0133-5. Epub 2014 Aug 22. PubMed PMID: 25146164. IF 3.698 (SCIE, CC, ESCI), CI=11 33. Shimizu Y, Sonoda A, Nogi C, Ogushi Y, Kanda R, Yamaguchi S, Nohara N, Aoki T, Yamada K, Nakata J, Io H, Kurusu A, Hamada C, Horikoshi S, Tomino Y. B-type (brain) natriuretic peptide and pruritus in hemodialysis patients. Int J Nephrol Renovasc Dis. 2014 Aug 25;7:329-35. doi: 10.2147/IJNRD.S65929. eCollection 2014. PubMed PMID: 25187733; PubMed Central PMCID: PMC4149441., IF NA (SCIE), CI=5 34. Wakabayashi K, Hamada C, Kanda R, Nakano T, Io H, Horikoshi S, Tomino Y. Oral Astaxanthin Supplementation Prevents Peritoneal Fibrosis in Rats. Perit Dial Int. 2015 Sep-Oct;35(5):506-16. doi: 10.3747/pdi.2013.00317. Epub 2014 Oct 7. PubMed PMID: 25292409; PubMed Central PMCID: PMC4597983., IF 1.934 (SCIE, CC, ESCI), CI=5 35. Yamahatsu A, Hamada C, Kaneko K, Io H, Nakata J, Tomino Y. Long-term outcome of encapsulating peritoneal sclerosis (EPS) patients in a single center. Clin Exp Nephrol. 2015 Oct;19(5):961-7. doi: 10.1007/s10157-015-1081-7. Epub 2015 Jan 23. PubMed PMID: 25612779., IF: 1.971 (SCIE, CC, ESCI), CI=5 36. Io H, Aizawa M, Funabiki K, Horikoshi S, Tomino Y. Impact of anaemia treatment for left ventricular remodelling prior to initiation of dialysis in chronic kidney disease patients: Efficacy and stability of long acting erythropoietin stimulating agents. Nephrology (Carlton). 2015 Dec;20 Suppl 4:7-13. doi: 10.1111/nep.12640. PubMed PMID: 26439537., IF 1.913 (SCIE, CC, ESCI), CI=2 37. Nohara N, Io H, Matsumoto M, Furukawa M, Okumura K, Nakata J, Shimizu Y, Horikoshi S, Tomino Y. Predictive factors associated with increased progression to dialysis in early chronic kidney disease (stage 1-3) patients. Clin Exp Nephrol. 2016 Oct;20(5):740-747. Epub 2015 Dec 26. PubMed PMID: 26707759., IF 1.971 (SCIE, CC, ESCI), CI=1 38. Nakata J, Io H, Watanabe T, Sasaki Y, Makita Y, Aoki T, Yanagawa H, Kanda R, Tomino Y. Impact of preoperative ultrasonography findings on the patency rate of vascular access in Japanese hemodialysis patients. Springerplus. 2016 Apr 14;5:462. doi: 10.1186/s40064-016-2082-z. eCollection 2016. PubMed PMID: 27119066; PubMed Central PMCID: PMC4831953., IF NA (NA), N=NA 39. Io H, Hara K, Nakata J, Sakamoto K, Tomino Y. Laparoscope Is a Useful Tool for Reducing and Drawing off a Peritoneal Dialysis Catheter in Peritoneal Dialysis Patients. Kidney Int Rep. 2016 Jun 23;1(2):93. doi: 10.1016/j.ekir.2016.06.001. eCollection 2016 Jul. PubMed PMID: 29142918; PubMed Central PMCID: PMC5678653., IF NA (SCIE, CC, ESCI), N=0 40. Idei M, Tabe Y, Hamada C, Miyake K, Takemura H, Io H, Wakita M, Horii T, Tomino Y, Ohsaka A, Miida T. Pancreatic lipase activity in overnight effluent predicts high transport status in peritoneal dialysis patients. Clin Chim Acta. 2016 Nov 1;462:65-70. doi: 10.1016/j.cca.2016.08.009. Epub 2016 Aug 13. PubMed PMID: 27531412., IF 2.735 (SCIE, CC, ESCI), CI=0 41. Kanda R, Io H, Nakata J, Makita Y, Sasaki Y, Matsumoto M, Wakabayashi K, Tomino Y, Suzuki Y. Evaluation of Long-Term Combination Therapy With Peritoneal Dialysis and Hemodialysis. Ther Apher Dial. 2017 Apr;21(2):180-184. doi: 10.1111/1744-9987.12517. Epub 2017 Feb 10. PubMed PMID: 28185405., IF 1.077 (SCIE, CC, ESCI), CI=4 42. Wakabayashi K, Io H, Nakata J, Nakamoto H, Sato M, Sasaki Y, Shimizu Y, Horikoshi S, Tomino Y, Suzuki Y. Effects of Cardiac Function with Postoperative Arteriovenous Fistula Blood Flow in Patients with Hemodialysis. Blood Purif. 2017;44(1):24-29. doi: 10.1159/000458146. Epub 2017 Feb 25. PubMed PMID: 28237983., IF 2.363 (SCIE, CC, ESCI), CI=2 43. Ikeda M, Terawaki H, Kanda E, Furuya M, Tanno Y, Nakao M, Maruyama Y, Maeda M, Higuchi C, Sakurada T, Kaneko T, Io H, Hashimoto K, Ueda A, Hirano K, Washida N, Yoshida H, Yoshikawa K, Taniyama Y, Harada K, Matsuo N, Okido I, Yokoo T. Interventional nephrology: current status and clinical impact in Japan. Clin Exp Nephrol. 2018 Apr;22(2):437-447. doi: 10.1007/s10157-017-1457-y. Epub 2017 Aug 2. PubMed PMID: 28770395; PubMed Central PMCID: PMC5838145., IF 1.971 (SCIE, CC, ESCI), CI=2 44. Io H, Suzuki Y. Strategy for Prevention of Left Ventricular Remodeling in Predialysis and Dialysis Patients. Contrib Nephrol. 2018;196:13-21. doi: 10.1159/000485691. Epub 2018 Jul 24. PubMed PMID: 30041199., IF NA (Book), N=0 45. Honda D, Ohsawa I, Shimizu Y, Maiguma M, Hidaka T, Suzuki H, Io H, Mano S, Takahara H, Rinno H, Tomino Y, Suzuki Y. Suffocation due to Acute Airway Edema in a Patient with Hereditary Angioedema Highlighted the Need for Urgent Improvements in Treatment Availability in Japan. Intern Med. 2018 Nov 1;57(21):3193-3197. doi: 10.2169/internalmedicine.9262-17. Epub 2018 Apr 27. PubMed PMID: 29709957; PubMed Central PMCID: PMC6262712., IF 0.956 (SCIE, CC, ESCI), CI=1 46. Maruyama Y, Higuchi C, Io H, Wakabayashi K, Tsujimoto H, Tsujimoto Y, Yuasa H., Ryuzaki M., Ito Y., Nakamoto H. Comparison of peritoneal dialysis and hemodialysis as first renal replacement therapy in patients with end-stage renal disease and diabetes: a systematic review. Ren Replace Ther 5, 44 (2019). https://doi.org/10.1186/s41100-019-0234-7, IF NA (NA), N=NA 47. Io H, Nakata J, Aoyama R, Inoshita H, Nakano T, Ishizaka M, Fukui M, Tomino Y, Suzuki Y. Far-infrared therapy for secondary vascular access patency of hemodialysis patients. Ren Replace Ther 5, 31 (2019). https://doi.org/10.1186/s41100-019-0224-9, IF NA (NA), N=NA 48. Shimizu Y, Nakata J, Maiguma M, Shirotani Y, Fukuzaki H, Nohara N, Io H, Suzuki Y. Predictive Value of 1-Week Postoperative Ultrasonography Findings for the Patency Rate of Arteriovenous Fistula. Kidney Int Rep. 2020 Aug 6;5(10):1746-1752 49. Kuwasawa-Iwasaki M, Io H, Muto M, Ichikawa S, Wakabayashi K, Kanda R, Nakata J, Nohara N, Tomino Y, Suzuki Y. Effects of L-Carnitine Supplementation in Patients Receiving Hemodialysis or Peritoneal Dialysis. Nutrients. 2020 Nov 1;12(11):3371. doi: 10.3390/nu12113371. 50. Io H, Nakata J, Inoshita H, Ishizaka M, Tomino Y, Suzuki Y. Relationship among Left Ventricular Hypertrophy, Cardiovascular Events, and Preferred Blood Pressure Measurement Timing in Hemodialysis Patients. J Clin Med. 2020 Oct 30;9(11):3512. doi: 10.3390/jcm9113512. 51. Ueno Y, Saito A, Nakata J, Kamagata K, Taniguchi D, Motoi Y, Io H, Andica C, Shindo A, Shiina K, Miyamoto N, Yamashiro K, Urabe T, Suzuki Y, Aoki S, Hattori N. Possible Neuroprotective Effects of l-Carnitine on White-Matter Microstructural Damage and Cognitive Decline in Hemodialysis Patients. Nutrients. 2021 Apr 14;13(4):1292. doi: 10.3390/nu13041292. 52. Fukuzaki H, Nakata J, Nojiri S, Shimizu Y, Kano T, Shirotani Y, Maeda T, Nohara N, Io H, Suzuki Y. Negative-pressure wound therapy is effective for peritoneal dialysis catheter exit-site management in the early postoperative period. Sci Rep. 2022 Jan 7;12(1):70. doi: 10.1038/s41598-021-03878-5. 53. Shimizu Y, Wakabayashi K, Nakata J, Io H, Hamada C, Tomino Y, Suzuki Y. The Influence of an Unexpected Switch of Hemodialysis Facilities on the Quality of Life (QOL) in Hemodialysis Patients. Int J Nephrol Renovasc Dis. 2022 Apr 13;15:151-160. doi: 10.2147/IJNRD.S358915. eCollection 2022. 54. Endo D, Yamamoto T, Kajimoto K, Matsushita S, Dohi S, Shimada A, Yokoyama Y, Io H, Suzuki Y, Tabata M, Amano A. Coronary Artery Bypass Grafting in Patients with Chronic Kidney Disease: Chronic Kidney Disease Has an Independent Adverse Effect on the Long-Term Outcome of Coronary Artery Bypass Grafting. Biomed Res Int. 2022 Apr 26;2022:4994970. doi: 10.1155/2022/4994970. eCollection 2022. 55. Kano T, Io H, Nakata J, Sasaki Y, Muto M, Shimizu Y, Fukao Y, Fukuzaki H, Maeda T, Hosoya R, Suzuki Y. Impact of Transferrin Saturation and Anemia on Radial Artery Calcification in Patients with End-Stage Kidney Disease. Nutrients. 2022 Oct 13;14(20):4269. doi: 10.3390/nu14204269. 56. Io H, Muto M, Sasaki Y, Ishizaka M, Kano T, Fukuzaki H, Maeda T, Shimizu Y, Nakata J, Suzuki Y. Impact of anemia treatment for left ventricular hypertrophy using long-acting erythropoietin-stimulating agents from the pre-dialysis to maintenance dialysis period in patients with chronic kidney disease, retrospective longitudinal cohort study. BMC Nephrol. 2023 Mar 25;24(1):74. doi: 10.1186/s12882-023-03133-1. 57. Fukuzaki H, Nakata J, Nojiri S, Shimizu Y, Shirotani Y, Maeda T, Kano T, Mishiro M, Nohara N, Io H, Suzuki Y. Outpatient clinic specific for end-stage renal disease improves patient survival rate after initiating dialysis. Sci Rep. 2023 Apr 12;13(1):5991. doi: 10.1038/s41598-023-31636-2. 58. Muto M, Sasaki Y, Kano T, Fukao Y, Hosoya R, Nomura T, Sugita M, Io H, Suzuki Y. Successful Management of Critical Acute Respiratory Distress Syndrome Following COVID-19 through Extracorporeal Membrane Oxygenation in a Patient with Concurrent Nephrotic Syndrome Relapse. Intern Med. 2023 Aug 9. doi: 10.2169/internalmedicine.2293-23. Online ahead of print. 59. Maeda T, Io H, Hara K, Nakata J, Ishizaka M, Shimizu Y, Shirotani Y, Fukuzaki H, Suzuki Y. Laparoscopic observations of adhesions between peritoneal dialysis catheters and intraperitoneal organs: A retrospective, observational study. Nephrology (Carlton). 2023 Aug 21. doi: 10.1111/nep.14230. Online ahead of print. 60. Sakurada T, Kojima S, Yamada S, Koitabashi K, Taki Y, Matsui K, Murasawa M, Kawarazaki H, Shimizu S, Kobayashi H, Asai T, Hashimoto K, Hoshino T, Sugitani S, Maoka T, Nagase A, Sato H, Fukuoka K, Sofue T, Koibuchi K, Nagayama K, Washida N, Koide S, Okamoto T, Ishii D, Furukata S, Uchiyama K, Takahashi S, Nishizawa Y, Naito S, Toda N, Naganuma T, Kikuchi H, Suzuki T, Komukai D, Kimura T, Io H, Yoshikawa K, Naganuma T, Morishita M, Oshikawa J, Tamagaki K, Fujisawa H, Ueda A, Kanaoka T, Nakamura H, Yanagi M, Udagawa T, Yoneda T, Sakai M, Gunji M, Osaki S, Saito H, Yoshioka Y, Kaneshiro N. A multi-institutional, observational study of outcomes after catheter placement for peritoneal dialysis in Japan. Perit Dial Int. 2023 Aug 26:8968608231193240. doi: 10.1177/08968608231193240. Online ahead of print. 61. Hiroaki Io, Junichiro Nakata, Hiroyuki Inoshita,Toshiki Kano, Masanori Ishizaka,Masahiro Muto Yu Sasak, Takuya Maeda , Haruna Fukuzaki, Yuki Shimizu,Yusuke Suzuki. Literature review: Combined therapy with peritoneal dialysis and hemodialysis as renal replacement therapy. Renal Replacement Therapy volume 8, Article number: 38 (2022) 和文原著 1. Io H, Takeda Y, Okumura K, Sakamoto N, Obayashi K, Suzuki S, Funabiki K, Horikoshi S, Shirato I, Tomino Y: A case of gastric antral vascular ectasia (GAVE) with chronic renal failure. Nippon Jinzo Gakkai Shi.43:82-7. Review. Japanese, 2001 2. 高木美幸, 井尾浩章, 関口嘉, 呂勇樹, 金子佳代, 濱田千江子, 富野康日己: 腹膜透析導入1年後に横隔膜ヘルニア・鼠径ヘルニア・横隔膜交通症を合併した１症例, 日本透析医学会誌, Vol. 39: pp1487-1491, 2006 3. 仲本宙高, 佐藤倫子, 関口嘉, 合田朋仁, 井尾浩章, 金子佳代, 来栖厚, 長谷川貴征, 船曳和彦, 前田国見, 濱田千江子, 堀越哲, 富野康日己: 順天堂医院腎・高血圧内科のおける血液透析療法の検討, 順天堂医学 55: pp289-293, 2009 4. 鈴木日和, 井尾浩章, 浅沼克彦, 武田之彦, 大澤勲, 堀越哲, 長谷川敏男, 溝口将之, 池田志斈, 富野康日己: 劣性栄養障害型先天性表皮水疱症に長期留置型カテーテルを用いて維持血液透析を導入した1症例, 日本透析医学会雑誌, Vol. 42: pp.899-904, 2009 5. 合田朋仁, 岡寛, 後藤博道, 佐藤倫子, 谷本光生, 井尾浩章, 清水芳男, 濱田千江子, 堀越哲, 富野康日己: 血液透析患者におけるPainVision® PS-2100を用いた電流知覚閾値（CPT）の検討, 日本透析医学会雑誌, Vol. 42: pp.77-83, 2009 6. 神田怜生, 濱田千江子, 下山正博, 柳川宏之, 佐藤信之, 大崎憲, 長濱莉莉, 田中裕一, 井尾浩章, 金丸裕, 大澤勲, 堀越哲, 須賀新, 寺尾泰久, 荻島大貴, 五藤倫敏, 仙石博信, 坂本一博, 荒川敦, 八尾隆史, 富野康日己: 腹膜透析（PD）カテーテル抜去後に左卵巣粘液性嚢胞性腫瘍の穿破による腹膜偽粘液腫を発症した1症例, 日本透析医学会雑誌, Vol. 43: pp.953-958, 2010 7. 富野康日己、淺沼克彦、井尾浩章、鈴木仁、田中裕一、中田純一郎、小林則善、武田之彦、稲見裕子、清水芳男、柘植俊直、鈴木祐介、大澤勲、来栖厚、濱田千江子、堀越哲、若林道郎、青木竜弥、金口泰彦、彰一祐: 高カリウム血症を伴う慢性腎臓病(CKD)患者に対するポリスチレンスルホン酸カルシウムゼリーの長期投与効果の検討, Ther. Res., 31: 1471-1480, 2010 8. 小林則善, 佐藤信之, 島岡哲太郎, 谷本光生, 井尾浩章, 合田朋仁, 大澤勲, 濱田千江子, 堀越哲, 神谷康司, 富野康日己: 62歳で血液透析を施行しえている糖原病I型(von Gierke病)の１例, 日本透析医学会誌, Vol.44: pp163-167, 2011 9. 井尾浩章、原一彰、神田怜生、中野貴則、若林啓一、中田純一郎、青木竜弥、柳川宏之、濱田千江子、富野康日己: 腹膜透析患者の腹腔所見：腹膜透析６年で計画離脱した症例の腹腔鏡所見, 腎と透析別冊　腹膜透析 2014 10. 井尾浩章、島岡哲太郎、関口嘉、井沼治朗、原一彰、濱田千江子、富野康日己：ミニレクチャー腹膜と血管、腎と透析　別冊　腹膜透析 33-6, 2015 11. 井尾浩章、原一彰、神田怜生、中田純一郎、中野貴則、井下博之、石坂匡則、武田之彦、前田国見、鈴木祐介；腹膜透析離脱：早期腹膜透析離脱の原因と対策および腹膜透析離脱時期. 腎と透析　別冊　「腹膜透析2017」、東京医学社、東京、p-、2017 12. 井尾浩章、若林啓一、神田怜生、中田純一郎、井下博之、中野貴則、石坂匡則、鈴木祐介；HD導入時のシャント管理：心機能とシャント血流を評価する；腎と透析　別冊　「腎不全外科2017」、東京医学社、東京、p-、2017 13. 井下博之、井尾浩章、石坂匡則、中野貴則、武田之彦、前田国見、鈴木祐介腹膜炎により腹膜透析用カテーテルを一度抜去するも再挿入し、その後再抜去した症例の腹腔鏡所見の変遷: 腎と透析　別冊　「腹膜透析2018」、東京医学社、東京、p-、2018 14. 若林啓一、井尾浩章、神田怜生、中田純一郎、鈴木祐介: PDHD併用療法におけるシャント血流量と心機能への影響: 腎と透析　別冊　「腹膜透析2018」、東京医学社、東京、p-、2018 15. 中野貴則、井尾浩章、井下博之、石坂匡則、中田純一郎、武田之彦、前田国見、鈴木祐介：　腹膜透析（PD）患者のPD継続に関わる因子の検討：　腎と透析　別冊　「腹膜透析2018」、東京医学社、東京、p-、2018 16. 井尾浩章、中田純一郎、青山留未、井下博之、中野貴則、石坂匡則、福井光峰、富野康日己、鈴木祐介：　血液透析患者の内シャント狭窄予防における：日本透析医会雑誌 (株）三秀舎 Vol. 33　No. 2　2018 17. 松山（作本）容子、井尾浩章、中野貴則、石坂匡則、毎熊政行、井下博之、鈴木祐介:腹膜透析患者における酸性イコデキストリン液から中性イコデキストリン液への切り替え比較検討: 腎と透析　別冊　「腹膜透析2019」、東京医学社、東京、p94-95、2019 英文著書 1. Io Hiroaki, Tomino Yasuhiko: Left Ventricular Hypertrophy (LVH): Prevalence, Risk Factors and Treatment, Review chapter; Predictive factors associated with left ventricular (LV) hypertrophy in pre-dialysis and dialysis patients: Nova Science Publishers, 2014 2. Io Hiroaki, Kanda Reo, Nakata Junichiro, Suzuki Yusuke; Evaluation of long-term Combination Therapy With Peritoneal Dialysis and Hemodialysis: International Society For Peritoneal Dialysis (ISPD) Asian-Pacific Chapter Newsletter 15(3) Fall; 3-4, 2017 和文著書 1. 井尾浩章、富野康日己: 透析用灌流用剤, ポケット判　治療薬UP-TO-DAT 2010、矢崎義雄、メディカルレビュー社、442-443、東京、2010　 2. 井尾浩章: 急性腎盂腎炎, 病気とけがの知識　腎臓尿路の病気、家庭医学大全科、髙久史麿、猿田享男、北村惣一郎、福井次矢（総合監修）、富野康日己（各編別監修）、法研、1958-1959、東京、2010 3. 井尾浩章、富野康日己: バスキュラーアクセスとは, , Q&A 透析ナーシング総合医学社；p18-19, 2011 4. 井尾浩章：腹膜透析関連腹膜炎　peritoneal dialysis (PD) related peritonitis, 今日の治療指針p549-550, ２０１２年版 5. 井尾浩章: 検査編　高血圧検査、治療編非薬物治療血液透析・腹膜透析疾患編全身疾患に伴う心血管異常腎不全（急性・慢性）, 循環器専門医研修テキスト P63-67, P111-113, P327-330, 2011 6. 井尾浩章: 透析・腎移植, 生活習慣病・腎臓病・高血圧対策Q&A100, p101-102, 2011 7. 井尾浩章: 「内科医のための薬の禁忌１００」腎不全患者に対する糖尿病治療薬やアルミニウム含有胃腸薬の投与,血液透析および腹膜透析患者に対しシタグリプチン（ジャヌビア、グラクティブ）などを投与してはならない, 慢性腎不全患者またはクレアチニンクリアランスが50ml/分以下の腎機能障害のある患者に対し、リバビリン（レベトール）を投与してはならない; 内科医のための薬の禁忌１００, p141-144, 2011 8. 井尾浩章: 動脈血O2分圧(PO2)、120　動脈血CO2分圧(PCO2), 臨床検査基準express, 2012 9. 井尾浩章: 低ナトリウム血症をきたしやすい降圧薬は何ですか？低ナトリウム血症の治療薬は何ですか？,腎性貧血に用いられる注射薬は何ですか？その効果と副作用は何ですか？また腎性貧血に鉄剤を用いてもいいですか？, 腎臓病・高血圧と薬剤　実践Q&A, p131-134, 2012 10. 井尾浩章: 腎機能検査の実際と臨床的意義1. 関連血液検査（臨床的意義）, 尿検査・腎機能検査の実際と臨床的意義, p108-130, 2013 11. 井尾浩章: .慢性腎臓病　e)急性腎不全, スマート栄養管理術100　－栄養管理が重要であるこれだけの理由, p137-141, 2013 12. 井尾浩章: 全身疾患による腎障害; アミロイド腎症、クリオグロブリン血症に伴う腎障害, Newエッセンシャル腎臓内科学, 2014 13. 井尾浩章；腹腔鏡：ぺリトネアルアクセスからカテーテル修復・抜去までLaparoscope is to use for only placement of peritoneal dialysis catheter but also reducing and drawing off in peritoneal dialysis patients. 実践インターベンショナルネフロロジー；インターベンショナルネフロロジー研究会、東京医学社、東京、p-、2016 14. 井尾浩章；超音波診断：バスキュラーアクセスの術前・術後評価Evaluation by ultrasound for pre and post-operative state of vascular access in hemodialysis patients. 実践インターベンショナルネフロロジー；インターベンショナルネフロロジー研究会、東京医学社、東京、p-、2016 15. 中田純一郎, 井尾浩章, 堀賢；国際基準から学ぶ透析医療の質・安全：感染管理の国際基準. 臨床透析、東京、32巻9号 1143-1150, 2016 16. 井尾浩章、編著：富野康日己；慢性腎臓病患者は歯槽骨の骨量が下がりやすいのはなぜ？；歯科医が押さえておきたい生活習慣病Q&A78、歯科総合出版社、東京、p- 2017 17. 井尾浩章、編著：富野康日己；成人における尿検査（各論）急性腎障害(AKI)の尿所見の特徴と診かた；『尿検査のみかた、考えかた』、中外医学社、東京、p-、2017 18. 井尾浩章、編著：富野康日己；クリオグロブリン血症・アミロイド腎：Newエッセンシャル腎臓内科学、医歯薬出版、東京、p-、2018 19. 井尾浩章、編著：富野康日己；シャント管理におけるフィラピー（FIRAPY）の有用性：血液透析患者さんのためのシャント管理とフットケアの新しい治療法－FIRAPYの効果―、広稜社、東京、p90-101、2018 20. 井尾浩章、編著：岡田一義・橋本寛文・水口　潤【総論】腹膜透析と適正体重；　腹膜透析診療指針、東京医学社、東京、39-42.2019 英文報告その他 1. Io Hiroaki: Experience of peritoneal dialysis (PD) catheter set up- Prevent PD patients from PD catheter’s complications – Taiwan Society of Nephrology: December 14, 2014 2. Sekiguchi Yoshimi, Hara kazuaki, Io Hiroaki, Nakano Takanori, Nakata Junichiro, Maeda Kunimi and Suzuki Yusuke；Laparoscopic evaluation of morphologic changes in the peritoneum of peritoneal dialysis patients；17th Congress of International Society of Peritoneal Dialysis May 5-8, 2018 3. Io Hiroaki, Sekiguchi Yoshimi, Nakano Takanori, Nakata Junichiro,Inoshita Hiroyuki, Ishizaka Masanori, Maeda Kunimi and Suzuki Yusuke；Predictive factors for maintaining residual renal function and associated factors for left ventricular hypertrophy with regards to a therapeutic strategy for a combination therapy with peritoneal dialysis and hemodialysis patients；17th Congress of International Society of Peritoneal Dialysis May 5-8, 2018 4. Maeda T, Io H, Hara K, Nakata J, Maiguma M, Ishizaka M, Sakumoto Y, Suzuki Y；Laparoscope is a useful tool for decannulation of a peritoneal dialysis cathter in peritoneal dialysis patient.；9th Asia Pacific Chapter Meeting of International Society for Peritoneal Dialysis (APCM-ISPD 2019) 5. Io H, Hara K, Wakabayashi K, Maeda T, Nakata J, Sekiguchi Y, Suzuki Y；Multicenter laparoscopic evaluation of peritoneal dialysis patients.；9th Asia Pacific Chapter Meeting of International Society for Peritoneal Dialysis (APCM-ISPD 2019) 和文報告その他 1. 井尾浩章: 日本透析医学会　【ワークショップ】;テーマ：透析導入患者の予後向上のための保存期からの取り組み;心血管合併症の危険因子である心筋重量指数(Left ventricular mass index: LVMI)と左房容積指数(Left atrium volume index: LAVi)の改善のために、『心エコー所見を活用する, 日本透析医学会学術集会総会　パシフィコ横浜　2011.6.18 2. 井尾浩章: 【シンポジウム】腹膜透析患者における腹腔鏡の有用性-トラブル時の対応-東京PD研究会 2012,5,12 3. 井尾浩章: 日本透析医学会　【ワークショップ】：日々対応する合併症; テーマ：慢性心不全への対策；心血管合併症の予防のために心筋重量指数(Left ventricular mass index: LVMI)に関わる因子を検討する, 日本透析医学会学術集会総会札幌 2012,6,24 4. 井尾浩章: 日本腹膜透析学会【ワークショップ】：「中性液の価値を問う：形態と機能へのインパクト」腹膜炎の既往なく腹膜透析6年の経過で計画離脱した症例の腹腔鏡所見, 日本腹膜透析学会大阪 2013,9,27 5. 井尾浩章: 日本腹膜透析学会腹膜病理検討会：「腹膜と血管」日本腹膜透析学会　山形 2014,9,6 6. 井尾浩章；【シンポジウム（指定）セッション】：CME2 腎臓専門医と腹膜透析；早期腹膜透析離脱原因と対策および腹膜透析離脱時期；第５９回日本腎臓学会学術集会・総会 2016.6.19 7. 井尾浩章；【シンポジウム（指定）セッション】：早期離脱；早期腹膜透析離脱原因と対策および腹膜透析離脱時期；第２２回日本腹膜透析医学会学術集会・総会 2016.9.24 8. 井尾浩章、原一彰、中田純一郎、神田怜生；【シンポジウム】セッション：PD離脱；早期腹膜透析離脱の原因と対策および腹膜透析離脱時期Causes and prevention strategies for early-stage drop-out and withdrawal times in peritoneal dialysis ；日本腹膜透析医学会 2016.9.24 9. 井尾浩章；【シンポジウム】「腹膜透析」最新の知見：早期腹膜透析離脱の原因と対策；第64回長野県透析研究会学術集会 2016.10.2 10. 井尾浩章；【ランチョンセミナー】：慢性腎臓病患者への貧血治療戦略－心血管イベント抑制へのstrategy－；第62回日本透析医学会学術集会・総会 2017.6.17 11. 井尾浩章、若林啓一、神田怜生、中田純一郎、鈴木祐介；透析クリニックスタッフのためのワークショップ「HD導入」：HD導入時のシャント管理：心機能とシャント血流を評価する；第26回腎不全外科研究会 2017.7.9 12. 井尾浩章：【教育セミナー4】 ES-04 出口部管理 up to date　第23回日本腹膜透析医学会学術集会・総会 2017.10.7 13. 若林啓一、井尾浩章、神田怜生、中田純一郎、鈴木祐介：【シンポジウム10】 PDHD併用療法 PDHD併用療法におけるシャント血流量と心機能への影響　第23回日本腹膜透析医学会学術集会・総会 2017.10.7 14. 井尾浩章、竜崎崇和、櫻田勉、寺脇博之、岡田一義、土谷健;【シンポジウム１】「PD人材育成システムの構築」:第24回日本腹膜透析医学会学術集会・総会 2018.10.8 15. 井尾浩章;【ランチョンセミナー】「慢性腎臓病(CKD)診療における病診連携の重要性」; 第48回日本腎臓学会東部学術大会2018.10.20 16. 井尾浩章、中田純一郎、鈴木祐介; 【シンポジウム】透析患者の心血管イベント発症に影響をおよぼす因子と心肥大・血圧測定時期の検討;第64回日本透析医学会学術集会・総会 2019.6.29 17. 井尾浩章: 【教育セミナー】慢性腎臓病（CKD）への治療戦略; ;第652回内科学会関東地方会 2019.7.14 18. 井尾浩章: 【教育講演１】PD導入期管理;第25回日本腹膜透析医学会学術集会・総会; 2019.1122 19. 井尾浩章【ランチョンセミナー】進化をつづけるPD療法;第25回日本腹膜透析医学会学術集会・総会; 2019.1122 20. 井尾浩章、塚田三佐緒、櫻田勉、寺脇博之、竜崎崇和、岡田一義、土谷健: 【シンポジウム５】　PD認定医制度のあらまし;第25回日本腹膜透析医学会学術集会・総会; 2019.1122

研究テーマ

腎臓内科

研究業績（論文）

英文原著
1. Zheng YL, Liao J, Takeda Y, Io H, Kobata M, Kanamaru Y, Maeda A, Shou I,Igari J, Tomino Y. Determination of sensitivity and specificity of the Micral-Test II strip for detection of microalbuminuria in diabetic and nondiabetic patients. Nephron. 1999;81(4):455. PubMed PMID: 10095190., IF 2.085 (SCIE, CC, ESCI), CI=2
2. Kubota M, Kanazawa M, Takahashi Y, Io H, Ishiguro N, Tomino Y. Implantation of presternal catheter using Moncrief technique: aiming for fewer catheter-related complications. Perit Dial Int. 2001;21 Suppl 3:S205-8. PubMed PMID: 11887822., IF 1.934 (SCIE, CC, ESCI), CI=10
3. Io H, Takeda Y, Okumura K, Sakamoto N, Obayashi K, Suzuki S, Funabiki K, Horikoshi S, Shirato I, Tomino Y. [A case of gastric antral vascular ectasia (GAVE) with chronic renal failure]. Nihon Jinzo Gakkai Shi. 2001;43(2):82-7. Review. Japanese. PubMed PMID: 11280215., IF NA (NA), N=NA
4. Shimizu-Tokiwa A, Kobata M, Io H, Kobayashi N, Shou I, Funabiki K, Fukui M, Horikoshi S, Shirato I, Saito K, Tomino Y. Serum cystatin C is a more sensitive marker of glomerular function than serum creatinine. Nephron. 2002 Sep;92(1):224-6. PubMed PMID: 12187109., IF 2.085 (SCIE, CC, ESCI), CI=35
5. Io H, Hamada C, Ro Y, Ito Y, Hirahara I, Tomino Y. Morphologic changes of peritoneum and expression of VEGF in encapsulated peritoneal sclerosis rat models. Kidney Int. 2004 May;65(5):1927-36. PubMed PMID: 15086936., IF 8.306 (SCIE, CC, ESCI), CI=77
6. Io H, Hamada C, Fukui M, Horikoshi S, Tomino Y. Relationship between levels of urinary type IV collagen and renal injuries in patients with IgA nephropathy. J Clin Lab Anal. 2004;18(1):14-8. PubMed PMID: 14730552; PubMed Central PMCID: PMC6807931., IF 1.728 (SCIE, CC, ESCI), CI=10
7. Ro Y, Hamada C, Io H, Hayashi K, Hirahara I, Tomino Y. Rapid, simple, and reliable method for the diagnosis of CAPD peritonitis using the new MMP-9 test kit. J Clin Lab Anal. 2004;18(4):224-30. PubMed PMID: 15202114; PubMed Central PMCID: PMC6807828., IF 1.728 (SCIE, CC, ESCI), CI=11
8. Hamada C, Hayashi K, Shou I, Inaba M, Ro Y, Io H, Maeda K, Fukui M, Tomino Y. Pharmacokinetics of calcitriol and maxacalcitol administered into peritoneal dialysate bags in peritoneal dialysis patients. Perit Dial Int. 2005 Nov-Dec;25(6):570-5. PubMed PMID: 16411524. IF 1.934 (SCIE, CC, ESCI), CI=3
9. Ro Y, Hamada C, Inaba M, Io H, Kaneko K, Tomino Y. Inhibitory effects of matrix metalloproteinase inhibitor ONO-4817 on morphological alterations in chlorhexidine gluconate-induced peritoneal sclerosis rats. Nephrol Dial Transplant. 2007 Oct;22(10):2838-48. Epub 2007 Jun 2. PubMed PMID: 17545675., IF 4.198 (SCIE, CC, ESCI), CI=34
10. Inoshita H, Gohda T, Io H, Kaneko K, Hamada C, Horikoshi S, Tomino Y. Improvement of peritoneal calcification after parathyroidectomy in a peritoneal dialysis patient. Clin Nephrol. 2008 Jan;69(1):58-62. PubMed PMID: 18218318., IF 1.079 (SCIE, CC, ESCI), CI=8
11. Gohda T, Gotoh H, Tanimoto M, Sato M, Io H, Kaneko K, Hamada C, Tomino Y. Relationship between abdominal fat accumulation and insulin resistance in hemodialysis patients. Hypertens Res. 2008 Jan;31(1):83-8. doi: 10.1291/hypres.31.83. PubMed PMID: 18360022., IF 3.217 (SCIE, CC, ESCI), CI=31
12. Hotta Y, Kaneko K, Inuma J, Inami Y, Aruga S, Shimaoka T, Sekiguchi Y, Io H, Hamada C, Obinata M, Ueda M, Tomino Y. Establishment of a peritoneal mesothelial cell line from a transgenic rat harbouring the temperature-sensitive simian virus 40 large T-antigen gene. Nephrol Dial Transplant. 2010 Jun;25(6):1825-32. doi: 10.1093/ndt/gfp742. Epub 2010 Jan 18. PubMed PMID: 20083474., IF 4.198 (SCIE, CC, ESCI), CI=5
13. Io H, Ro Y, Sekiguchi Y, Shimaoka T, Inuma J, Hotta Y, Aruga S, Inami Y, Sat M, Kobayashi T, Masuda A, Kaneko K, Hamada C, Ohtaki E, Horikoshi S, Tomino Y. Cardiac function and structure in longitudinal analysis of echocardiography in peritoneal dialysis patients. Perit Dial Int. 2010 May-Jun;30(3):353-61. doi: 10.3747/pdi.2009.00007. Epub 2010 Mar 25. PubMed PMID: 20338970., IF 1.934 (SCIE, CC, ESCI), CI=10
14. Shimaoka T, Hamada C, Kaneko K, Io H, Sekiguchi Y, Aruga S, Inuma J, Inami Y, Hotta Y, Horikoshi S, Kumasaka T, Tomino Y. Quantitative evaluation and assessment of peritoneal morphologic changes in peritoneal dialysis patients. Nephrol Dial Transplant. 2010 Oct;25(10):3379-85. doi: 10.1093/ndt/gfq194. Epub 2010 Apr 22. PubMed PMID: 20466666., IF 4.198 (SCIE, CC, ESCI), CI=20
15. Furukawa M, Io H, Tanimoto M, Hagiwara S, Horikoshi S, Tomino Y. Predictive factors associated with the period of time before initiation of hemodialysis in CKD stages 4 and 5. Nephron Clin Pract. 2011;117(4):c341-7. doi: 10.1159/000321512. Epub 2010 Oct 15. PubMed PMID: 20948232., IF 2.085 (SCIE, CC, ESCI), CI=12
16. Io H, Matsumoto M, Okumura K, Sato M, Masuda A, Furukawa M, Nohara N, Tanimoto M, Kodama F, Hagiwara S, Gohda T, Shimizu Y, Tomino Y. Predictive factors associated with left ventricular hypertrophy at baseline and in the follow-up period in non-diabetic hemodialysis patients. Semin Dial. 2011 May-Jun;24(3):349-54. doi: 10.1111/j.1525-139X.2010.00759.x. Epub 2010 Aug 13. PubMed PMID: 20723158., IF 2.056 (SCIE, CC, ESCI), CI=12
17. Tomino Y, Shimizu Y, Hamada C, Kurusu A, Ohsawa I, Suzuki Y, Tsuge T, Io H, Kobayashi N, Takeda Y, Asanuma K, Tanaka Y, Suzuki H, Nakata J, Takara K, Horikoshi S. One-year results of an open-label study on antiproteinuric effect of benidipine in elderly patients with chronic kidney disease. J Nephrol. 2011 Nov-Dec;24(6):756-63. doi: 10.5301/JN.2011.6383. PubMed PMID: 21360472., IF 3.698 (SCIE, CC, ESCI), CI=7
18. Inami Y, Yamaji K, Sato M, Gohda T, Io H, Nawata M, Hamada C, Takasaki Y, Tomino Y. Effects of dialysis on the pharmacokinetics of salazosulfapyridine. Rheumatol Int. 2013 Feb;33(2):535-9. doi: 10.1007/s00296-011-2179-1. Epub 2011 Nov 12. PubMed PMID: 22080212., IF 2.200 (SCIE, CC, ESCI), CI=3
19. Sato M, Io H, Tanimoto M, Shimizu Y, Fukui M, Hamada C, Horikoshi S, Tomino Y. Relationship between preoperative radial artery and postoperative arteriovenous fistula blood flow in hemodialysis patients. J Nephrol. 2012 Sep-Oct;25(5):726-31. doi: 10.5301/jn.5000050. PubMed PMID: 22081294., IF 3.698 (SCIE, CC, ESCI), CI=6
20. Masuda A, Hagiwara S, Tanimoto M, Kodama F, Okumura K, Nohara N, Matsumoto M, Maiguma M, Omote K, Io H, Kurusu A, Ohsawa I, Shimizu Y, Hamada C, Horikoshi S, Tomino Y. Effects of acetate-free citrate dialysate on glycoxidation and lipid peroxidation products in hemodialysis patients. Nephron Extra. 2012 Sep 27;2(1):256-68. doi: 10.1159/000342258. Print 2012 Jan. PubMed PMID: 23599704; PubMed Central PMCID: PMC3567873., IF NA (ESCI), CI=6
21. Matsumoto M, Io H, Furukawa M, Okumura K, Masuda A, Seto T, Takagi M, Sato M, Nagahama L, Omote K, Hisada A, Horikoshi S, Tomino Y. Risk factors associated with increased left ventricular mass index in chronic kidney disease patients evaluated using echocardiography. J Nephrol. 2012 Sep-Oct;25(5):794-801. doi: 10.5301/jn.5000066. PubMed PMID: 22241636., IF 3.698 (SCIE, CC, ESCI), CI=24
22. Sekiguchi Y, Hamada C, Ro Y, Nakamoto H, Inaba M, Shimaoka T, Io H, Koyanagi I, Aruga S, Inuma J, Kaneko K, Hotta Y, Margetts PJ, Mochizuki H, Horikoshi S, Tomino Y. Differentiation of bone marrow-derived cells into regenerated mesothelial cells in peritoneal remodeling using a peritoneal fibrosis mouse model. J Artif Organs. 2012 Sep;15(3):272-82. doi: 10.1007/s10047-012-0648-2. Epub 2012 May 24. PubMed PMID: 22622710., IF 1.519 (SCIE, CC, ESCI), CI=14
23. Iida H, Hasegawa T, Okuma K, Io H, Tomino Y, Ikeda S. Successfully maintained hemodialysis for the treatment of chronic renal failure in a patient with Hallopeau-Siemens type recessive dystrophic epidermolysis bullosa. J Dermatol. 2012 Dec;39(12):1088-9. doi: 10.1111/j.1346-8138.2012.01617.x. Epub 2012 Jun 23. PubMed PMID: 22725264., IF 3.377 (SCIE, CC, ESCI), CI=1
24. Kanda R, Hamada C, Kaneko K, Nakano T, Wakabayashi K, Io H, Horikoshi S, Tomino Y. Pentraxin 3 as a new biomarker of peritoneal injury in peritoneal dialysis patients. J Artif Organs. 2013 Mar;16(1):66-73. doi: 10.1007/s10047-012-0663-3. Epub 2012 Sep 27. PubMed PMID: 23010754., IF 1.519 (SCIE, CC, ESCI), CI=7
25. Okumura K, Io H, Matsumoto M, Seto T, Takagi M, Masuda A, Furukawa M, Nagahama L, Omote K, Hisada A, Hamada C, Horikoshi S, Tomino Y. Predictive factors associated with change rates of LV hypertrophy and renal dysfunction in CKD patients. Clin Nephrol. 2013 Jan;79(1):7-14. doi: 10.5414/CN107569. PubMed PMID: 23036229., IF 1.079 (SCIE, CC, ESCI), CI=12
26. Sasaki Y, Shimizu Y, Nakata J, Kameda T, Muto M, Ohsawa I, Io H, Hamada C, Horikoshi S, Tomino Y. Thyroid storm masked by hemodialysis and glucocorticoid therapy in a patient with rheumatoid arthritis. Case Rep Nephrol Urol. 2012 Jan;2(1):6-10. doi: 10.1159/000336624. Epub 2012 Feb 16. PubMed PMID: 23197948; PubMed Central PMCID: PMC3482076., IF NA (NA), CI=0
27. Shimizu Y, Ishii A, Takahata A, Kajiyama T, Yamahatsu A, Io H, Kurusu A, Hamada C, Horikoshi S, Tomino Y. Campylobacter bacteremia in hemodialysis patients by eating raw meat - the importance of sanitary education. Case Rep Nephrol Urol. 2012 Jul;2(2):145-51. doi: 10.1159/000343499. Epub 2012 Oct 24. PubMed PMID: 23197970; PubMed Central PMCID: PMC3507274., IF NA (NA), CI=6
28. Kanda R, Hamada C, Kaneko K, Nakano T, Wakabayashi K, Hara K, Io H, Horikoshi S, Tomino Y. Paracrine effects of transplanted mesothelial cells isolated from temperature-sensitive SV40 large T-antigen gene transgenic rats during peritoneal repair. Nephrol Dial Transplant. 2014 Feb;29(2):289-300. doi: 10.1093/ndt/gft397. Epub 2013 Sep 29. PubMed PMID: 24081857; PubMed Central PMCID: PMC3910341., IF 4.198 (SCIE, CC, ESCI), CI=7
29. Nakamoto H, Hamada C, Shimaoka T, Sekiguchi Y, Io H, Kaneko K, Horikoshi S, Tomino Y. Accumulation of advanced glycation end products and beta 2-microglobulin in fibrotic thickening of the peritoneum in long-term peritoneal dialysis patients. J Artif Organs. 2014 Mar;17(1):60-8. doi: 10.1007/s10047-013-0741-1. Epub 2013 Dec 14. PubMed PMID: 24337623., IF 1.519 (SCIE, ESCI), CI=8
30. Inami Y, Hamada C, Seto T, Hotta Y, Aruga S, Inuma J, Azuma K, Io H, Kaneko K, Watada H, Tomino Y. Effect of AST-120 on Endothelial Dysfunction in Adenine-Induced Uremic Rats. Int J Nephrol. 2014;2014:164125. doi:10.1155/2014/164125. Epub 2014 Apr 14. PubMed PMID: 24829798; PubMed Central PMCID: PMC4009319. IF NA (SCIE), CI=15
31. Io H, Maeda K, Sekiguchi Y, Shimaoka T, Aruga S, Nakata J, Nakamoto H, Hotta Y, Koyanagi I, Inaba M, Kanda R, Nakano T, Wakabayashi K, Sasaki Y, Inuma J, Kaneko K, Hamada C, Fukui M, Tomino Y. Comparison between the fixation of peritoneal dialysis catheters to the peritoneal wall and the conventional placement technique: clinical experience and follow-up of a new implant technique for peritoneal dialysis catheters. Semin Dial. 2014 Jul-Aug;27(4):E42-7. doi: 10.1111/sdi.12165. Epub 2013 Nov 22. PubMed PMID: 24262039., IF 2.056 (SCIE, CC, ESCI), CI=1
32. Wakabayashi K, Hamada C, Kanda R, Nakano T, Io H, Horikoshi S, Tomino Y. Adipose-derived mesenchymal stem cells transplantation facilitate experimental peritoneal fibrosis repair by suppressing epithelial-mesenchymal transition. J Nephrol. 2014 Oct;27(5):507-14. doi: 10.1007/s40620-014-0133-5. Epub 2014 Aug 22. PubMed PMID: 25146164. IF 3.698 (SCIE, CC, ESCI), CI=11
33. Shimizu Y, Sonoda A, Nogi C, Ogushi Y, Kanda R, Yamaguchi S, Nohara N, Aoki T, Yamada K, Nakata J, Io H, Kurusu A, Hamada C, Horikoshi S, Tomino Y. B-type (brain) natriuretic peptide and pruritus in hemodialysis patients. Int J Nephrol Renovasc Dis. 2014 Aug 25;7:329-35. doi: 10.2147/IJNRD.S65929. eCollection 2014. PubMed PMID: 25187733; PubMed Central PMCID: PMC4149441., IF NA (SCIE), CI=5
34. Wakabayashi K, Hamada C, Kanda R, Nakano T, Io H, Horikoshi S, Tomino Y. Oral Astaxanthin Supplementation Prevents Peritoneal Fibrosis in Rats. Perit Dial Int. 2015 Sep-Oct;35(5):506-16. doi: 10.3747/pdi.2013.00317. Epub 2014 Oct 7. PubMed PMID: 25292409; PubMed Central PMCID: PMC4597983., IF 1.934 (SCIE, CC, ESCI), CI=5
35. Yamahatsu A, Hamada C, Kaneko K, Io H, Nakata J, Tomino Y. Long-term outcome of encapsulating peritoneal sclerosis (EPS) patients in a single center. Clin Exp Nephrol. 2015 Oct;19(5):961-7. doi: 10.1007/s10157-015-1081-7. Epub 2015 Jan 23. PubMed PMID: 25612779., IF: 1.971 (SCIE, CC, ESCI), CI=5
36. Io H, Aizawa M, Funabiki K, Horikoshi S, Tomino Y. Impact of anaemia treatment for left ventricular remodelling prior to initiation of dialysis in chronic kidney disease patients: Efficacy and stability of long acting erythropoietin stimulating agents. Nephrology (Carlton). 2015 Dec;20 Suppl 4:7-13. doi: 10.1111/nep.12640. PubMed PMID: 26439537., IF 1.913 (SCIE, CC, ESCI), CI=2
37. Nohara N, Io H, Matsumoto M, Furukawa M, Okumura K, Nakata J, Shimizu Y, Horikoshi S, Tomino Y. Predictive factors associated with increased progression to dialysis in early chronic kidney disease (stage 1-3) patients. Clin Exp Nephrol. 2016 Oct;20(5):740-747. Epub 2015 Dec 26. PubMed PMID: 26707759., IF 1.971 (SCIE, CC, ESCI), CI=1
38. Nakata J, Io H, Watanabe T, Sasaki Y, Makita Y, Aoki T, Yanagawa H, Kanda R, Tomino Y. Impact of preoperative ultrasonography findings on the patency rate of vascular access in Japanese hemodialysis patients. Springerplus. 2016 Apr 14;5:462. doi: 10.1186/s40064-016-2082-z. eCollection 2016. PubMed PMID: 27119066; PubMed Central PMCID: PMC4831953., IF NA (NA), N=NA
39. Io H, Hara K, Nakata J, Sakamoto K, Tomino Y. Laparoscope Is a Useful Tool for Reducing and Drawing off a Peritoneal Dialysis Catheter in Peritoneal Dialysis Patients. Kidney Int Rep. 2016 Jun 23;1(2):93. doi: 10.1016/j.ekir.2016.06.001. eCollection 2016 Jul. PubMed PMID: 29142918; PubMed Central PMCID: PMC5678653., IF NA (SCIE, CC, ESCI), N=0
40. Idei M, Tabe Y, Hamada C, Miyake K, Takemura H, Io H, Wakita M, Horii T, Tomino Y, Ohsaka A, Miida T. Pancreatic lipase activity in overnight effluent predicts high transport status in peritoneal dialysis patients. Clin Chim Acta. 2016 Nov 1;462:65-70. doi: 10.1016/j.cca.2016.08.009. Epub 2016 Aug 13. PubMed PMID: 27531412., IF 2.735 (SCIE, CC, ESCI), CI=0
41. Kanda R, Io H, Nakata J, Makita Y, Sasaki Y, Matsumoto M, Wakabayashi K, Tomino Y, Suzuki Y. Evaluation of Long-Term Combination Therapy With Peritoneal Dialysis and Hemodialysis. Ther Apher Dial. 2017 Apr;21(2):180-184. doi: 10.1111/1744-9987.12517. Epub 2017 Feb 10. PubMed PMID: 28185405., IF 1.077 (SCIE, CC, ESCI), CI=4
42. Wakabayashi K, Io H, Nakata J, Nakamoto H, Sato M, Sasaki Y, Shimizu Y, Horikoshi S, Tomino Y, Suzuki Y. Effects of Cardiac Function with Postoperative Arteriovenous Fistula Blood Flow in Patients with Hemodialysis. Blood Purif. 2017;44(1):24-29. doi: 10.1159/000458146. Epub 2017 Feb 25. PubMed PMID: 28237983., IF 2.363 (SCIE, CC, ESCI), CI=2
43. Ikeda M, Terawaki H, Kanda E, Furuya M, Tanno Y, Nakao M, Maruyama Y, Maeda M, Higuchi C, Sakurada T, Kaneko T, Io H, Hashimoto K, Ueda A, Hirano K, Washida N, Yoshida H, Yoshikawa K, Taniyama Y, Harada K, Matsuo N, Okido I, Yokoo T. Interventional nephrology: current status and clinical impact in Japan. Clin Exp Nephrol. 2018 Apr;22(2):437-447. doi: 10.1007/s10157-017-1457-y. Epub 2017 Aug 2. PubMed PMID: 28770395; PubMed Central PMCID: PMC5838145., IF 1.971 (SCIE, CC, ESCI), CI=2
44. Io H, Suzuki Y. Strategy for Prevention of Left Ventricular Remodeling in Predialysis and Dialysis Patients. Contrib Nephrol. 2018;196:13-21. doi: 10.1159/000485691. Epub 2018 Jul 24. PubMed PMID: 30041199., IF NA (Book), N=0
45. Honda D, Ohsawa I, Shimizu Y, Maiguma M, Hidaka T, Suzuki H, Io H, Mano S, Takahara H, Rinno H, Tomino Y, Suzuki Y. Suffocation due to Acute Airway Edema in a Patient with Hereditary Angioedema Highlighted the Need for Urgent Improvements in Treatment Availability in Japan. Intern Med. 2018 Nov 1;57(21):3193-3197. doi: 10.2169/internalmedicine.9262-17. Epub 2018 Apr 27. PubMed PMID: 29709957; PubMed Central PMCID: PMC6262712., IF 0.956 (SCIE, CC, ESCI), CI=1
46. Maruyama Y, Higuchi C, Io H, Wakabayashi K, Tsujimoto H, Tsujimoto Y, Yuasa H., Ryuzaki M., Ito Y., Nakamoto H. Comparison of peritoneal dialysis and hemodialysis as first renal replacement therapy in patients with end-stage renal disease and diabetes: a systematic review. Ren Replace Ther 5, 44 (2019). https://doi.org/10.1186/s41100-019-0234-7, IF NA (NA), N=NA
47. Io H, Nakata J, Aoyama R, Inoshita H, Nakano T, Ishizaka M, Fukui M, Tomino Y, Suzuki Y. Far-infrared therapy for secondary vascular access patency of hemodialysis patients. Ren Replace Ther 5, 31 (2019). https://doi.org/10.1186/s41100-019-0224-9, IF NA (NA), N=NA
48. Shimizu Y, Nakata J, Maiguma M, Shirotani Y, Fukuzaki H, Nohara N, Io H, Suzuki Y. Predictive Value of 1-Week Postoperative Ultrasonography Findings for the Patency Rate of Arteriovenous Fistula. Kidney Int Rep. 2020 Aug 6;5(10):1746-1752
49. Kuwasawa-Iwasaki M, Io H, Muto M, Ichikawa S, Wakabayashi K, Kanda R, Nakata J, Nohara N, Tomino Y, Suzuki Y. Effects of L-Carnitine Supplementation in Patients Receiving Hemodialysis or Peritoneal Dialysis. Nutrients. 2020 Nov 1;12(11):3371. doi: 10.3390/nu12113371.
50. Io H, Nakata J, Inoshita H, Ishizaka M, Tomino Y, Suzuki Y. Relationship among Left Ventricular Hypertrophy, Cardiovascular Events, and Preferred Blood Pressure Measurement Timing in Hemodialysis Patients. J Clin Med. 2020 Oct 30;9(11):3512. doi: 10.3390/jcm9113512.
51. Ueno Y, Saito A, Nakata J, Kamagata K, Taniguchi D, Motoi Y, Io H, Andica C, Shindo A, Shiina K, Miyamoto N, Yamashiro K, Urabe T, Suzuki Y, Aoki S, Hattori N. Possible Neuroprotective Effects of l-Carnitine on White-Matter Microstructural Damage and Cognitive Decline in Hemodialysis Patients. Nutrients. 2021 Apr 14;13(4):1292. doi: 10.3390/nu13041292.
52. Fukuzaki H, Nakata J, Nojiri S, Shimizu Y, Kano T, Shirotani Y, Maeda T, Nohara N, Io H, Suzuki Y. Negative-pressure wound therapy is effective for peritoneal dialysis catheter exit-site management in the early postoperative period. Sci Rep. 2022 Jan 7;12(1):70. doi: 10.1038/s41598-021-03878-5.
53. Shimizu Y, Wakabayashi K, Nakata J, Io H, Hamada C, Tomino Y, Suzuki Y. The Influence of an Unexpected Switch of Hemodialysis Facilities on the Quality of Life (QOL) in Hemodialysis Patients. Int J Nephrol Renovasc Dis. 2022 Apr 13;15:151-160. doi: 10.2147/IJNRD.S358915. eCollection 2022.
54. Endo D, Yamamoto T, Kajimoto K, Matsushita S, Dohi S, Shimada A, Yokoyama Y, Io H, Suzuki Y, Tabata M, Amano A. Coronary Artery Bypass Grafting in Patients with Chronic Kidney Disease: Chronic Kidney Disease Has an Independent Adverse Effect on the Long-Term Outcome of Coronary Artery Bypass Grafting. Biomed Res Int. 2022 Apr 26;2022:4994970. doi: 10.1155/2022/4994970. eCollection 2022.
55. Kano T, Io H, Nakata J, Sasaki Y, Muto M, Shimizu Y, Fukao Y, Fukuzaki H, Maeda T, Hosoya R, Suzuki Y. Impact of Transferrin Saturation and Anemia on Radial Artery Calcification in Patients with End-Stage Kidney Disease. Nutrients. 2022 Oct 13;14(20):4269. doi: 10.3390/nu14204269.
56. Io H, Muto M, Sasaki Y, Ishizaka M, Kano T, Fukuzaki H, Maeda T, Shimizu Y, Nakata J, Suzuki Y. Impact of anemia treatment for left ventricular hypertrophy using long-acting erythropoietin-stimulating agents from the pre-dialysis to maintenance dialysis period in patients with chronic kidney disease, retrospective longitudinal cohort study. BMC Nephrol. 2023 Mar 25;24(1):74. doi: 10.1186/s12882-023-03133-1.
57. Fukuzaki H, Nakata J, Nojiri S, Shimizu Y, Shirotani Y, Maeda T, Kano T, Mishiro M, Nohara N, Io H, Suzuki Y. Outpatient clinic specific for end-stage renal disease improves patient survival rate after initiating dialysis. Sci Rep. 2023 Apr 12;13(1):5991. doi: 10.1038/s41598-023-31636-2.
58. Muto M, Sasaki Y, Kano T, Fukao Y, Hosoya R, Nomura T, Sugita M, Io H, Suzuki Y. Successful Management of Critical Acute Respiratory Distress Syndrome Following COVID-19 through Extracorporeal Membrane Oxygenation in a Patient with Concurrent Nephrotic Syndrome Relapse. Intern Med. 2023 Aug 9. doi: 10.2169/internalmedicine.2293-23. Online ahead of print.
59. Maeda T, Io H, Hara K, Nakata J, Ishizaka M, Shimizu Y, Shirotani Y, Fukuzaki H, Suzuki Y. Laparoscopic observations of adhesions between peritoneal dialysis catheters and intraperitoneal organs: A retrospective, observational study. Nephrology (Carlton). 2023 Aug 21. doi: 10.1111/nep.14230. Online ahead of print.
60. Sakurada T, Kojima S, Yamada S, Koitabashi K, Taki Y, Matsui K, Murasawa M, Kawarazaki H, Shimizu S, Kobayashi H, Asai T, Hashimoto K, Hoshino T, Sugitani S, Maoka T, Nagase A, Sato H, Fukuoka K, Sofue T, Koibuchi K, Nagayama K, Washida N, Koide S, Okamoto T, Ishii D, Furukata S, Uchiyama K, Takahashi S, Nishizawa Y, Naito S, Toda N, Naganuma T, Kikuchi H, Suzuki T, Komukai D, Kimura T, Io H, Yoshikawa K, Naganuma T, Morishita M, Oshikawa J, Tamagaki K, Fujisawa H, Ueda A, Kanaoka T, Nakamura H, Yanagi M, Udagawa T, Yoneda T, Sakai M, Gunji M, Osaki S, Saito H, Yoshioka Y, Kaneshiro N. A multi-institutional, observational study of outcomes after catheter placement for peritoneal dialysis in Japan. Perit Dial Int. 2023 Aug 26:8968608231193240. doi: 10.1177/08968608231193240. Online ahead of print.
61. Hiroaki Io, Junichiro Nakata, Hiroyuki Inoshita,Toshiki Kano, Masanori Ishizaka,Masahiro Muto Yu Sasak, Takuya Maeda
, Haruna Fukuzaki, Yuki Shimizu,Yusuke Suzuki. Literature review: Combined therapy with peritoneal dialysis and hemodialysis as renal replacement therapy. Renal Replacement Therapy volume 8, Article number: 38 (2022)

和文原著
1. Io H, Takeda Y, Okumura K, Sakamoto N, Obayashi K, Suzuki S, Funabiki K, Horikoshi S, Shirato I, Tomino Y: A case of gastric antral vascular ectasia (GAVE) with chronic renal failure. Nippon Jinzo Gakkai Shi.43:82-7. Review. Japanese, 2001
2. 高木美幸, 井尾浩章, 関口嘉, 呂勇樹, 金子佳代, 濱田千江子, 富野康日己: 腹膜透析導入1年後に横隔膜ヘルニア・鼠径ヘルニア・横隔膜交通症を合併した１症例, 日本透析医学会誌, Vol. 39: pp1487-1491, 2006
3. 仲本宙高, 佐藤倫子, 関口嘉, 合田朋仁, 井尾浩章, 金子佳代, 来栖厚, 長谷川貴征, 船曳和彦, 前田国見, 濱田千江子, 堀越哲, 富野康日己: 順天堂医院腎・高血圧内科のおける血液透析療法の検討, 順天堂医学 55: pp289-293, 2009
4. 鈴木日和, 井尾浩章, 浅沼克彦, 武田之彦, 大澤勲, 堀越哲, 長谷川敏男, 溝口将之, 池田志斈, 富野康日己: 劣性栄養障害型先天性表皮水疱症に長期留置型カテーテルを用いて維持血液透析を導入した1症例, 日本透析医学会雑誌, Vol. 42: pp.899-904, 2009
5. 合田朋仁, 岡寛, 後藤博道, 佐藤倫子, 谷本光生, 井尾浩章, 清水芳男, 濱田千江子, 堀越哲, 富野康日己: 血液透析患者におけるPainVision® PS-2100を用いた電流知覚閾値（CPT）の検討, 日本透析医学会雑誌, Vol. 42: pp.77-83, 2009
6. 神田怜生, 濱田千江子, 下山正博, 柳川宏之, 佐藤信之, 大崎憲, 長濱莉莉, 田中裕一, 井尾浩章, 金丸裕, 大澤勲, 堀越哲, 須賀新, 寺尾泰久, 荻島大貴, 五藤倫敏, 仙石博信, 坂本一博, 荒川敦, 八尾隆史, 富野康日己: 腹膜透析（PD）カテーテル抜去後に左卵巣粘液性嚢胞性腫瘍の穿破による腹膜偽粘液腫を発症した1症例, 日本透析医学会雑誌, Vol. 43: pp.953-958, 2010
7. 富野康日己、淺沼克彦、井尾浩章、鈴木仁、田中裕一、中田純一郎、小林則善、武田之彦、稲見裕子、清水芳男、柘植俊直、鈴木祐介、大澤勲、来栖厚、濱田千江子、堀越哲、若林道郎、青木竜弥、金口泰彦、彰一祐: 高カリウム血症を伴う慢性腎臓病(CKD)患者に対するポリスチレンスルホン酸カルシウムゼリーの長期投与効果の検討, Ther. Res., 31: 1471-1480, 2010
8. 小林則善, 佐藤信之, 島岡哲太郎, 谷本光生, 井尾浩章, 合田朋仁, 大澤勲, 濱田千江子, 堀越哲, 神谷康司, 富野康日己: 62歳で血液透析を施行しえている糖原病I型(von Gierke病)の１例, 日本透析医学会誌, Vol.44: pp163-167, 2011
9. 井尾浩章、原一彰、神田怜生、中野貴則、若林啓一、中田純一郎、青木竜弥、柳川宏之、濱田千江子、富野康日己: 腹膜透析患者の腹腔所見：腹膜透析６年で計画離脱した症例の腹腔鏡所見, 腎と透析別冊　腹膜透析 2014
10. 井尾浩章、島岡哲太郎、関口嘉、井沼治朗、原一彰、濱田千江子、富野康日己：ミニレクチャー腹膜と血管、腎と透析　別冊　腹膜透析 33-6, 2015
11. 井尾浩章、原一彰、神田怜生、中田純一郎、中野貴則、井下博之、石坂匡則、武田之彦、前田国見、鈴木祐介；腹膜透析離脱：早期腹膜透析離脱の原因と対策および腹膜透析離脱時期. 腎と透析　別冊　「腹膜透析2017」、東京医学社、東京、p-、2017
12. 井尾浩章、若林啓一、神田怜生、中田純一郎、井下博之、中野貴則、石坂匡則、鈴木祐介；HD導入時のシャント管理：心機能とシャント血流を評価する；腎と透析　別冊　「腎不全外科2017」、東京医学社、東京、p-、2017
13. 井下博之、井尾浩章、石坂匡則、中野貴則、武田之彦、前田国見、鈴木祐介腹膜炎により腹膜透析用カテーテルを一度抜去するも再挿入し、その後再抜去した症例の腹腔鏡所見の変遷: 腎と透析　別冊　「腹膜透析2018」、東京医学社、東京、p-、2018
14. 若林啓一、井尾浩章、神田怜生、中田純一郎、鈴木祐介: PDHD併用療法におけるシャント血流量と心機能への影響: 腎と透析　別冊　「腹膜透析2018」、東京医学社、東京、p-、2018
15. 中野貴則、井尾浩章、井下博之、石坂匡則、中田純一郎、武田之彦、前田国見、鈴木祐介：　腹膜透析（PD）患者のPD継続に関わる因子の検討：　腎と透析　別冊　「腹膜透析2018」、東京医学社、東京、p-、2018
16. 井尾浩章、中田純一郎、青山留未、井下博之、中野貴則、石坂匡則、福井光峰、富野康日己、鈴木祐介：　血液透析患者の内シャント狭窄予防における：日本透析医会雑誌 (株）三秀舎 Vol. 33　No. 2　2018
17. 松山（作本）容子、井尾浩章、中野貴則、石坂匡則、毎熊政行、井下博之、鈴木祐介:腹膜透析患者における酸性イコデキストリン液から中性イコデキストリン液への切り替え比較検討: 腎と透析　別冊　「腹膜透析2019」、東京医学社、東京、p94-95、2019

英文著書
1. Io Hiroaki, Tomino Yasuhiko: Left Ventricular Hypertrophy (LVH): Prevalence, Risk Factors and Treatment, Review chapter; Predictive factors associated with left ventricular (LV) hypertrophy in pre-dialysis and dialysis patients: Nova Science Publishers, 2014
2. Io Hiroaki, Kanda Reo, Nakata Junichiro, Suzuki Yusuke; Evaluation of long-term Combination Therapy With Peritoneal Dialysis and Hemodialysis: International Society For Peritoneal Dialysis (ISPD) Asian-Pacific Chapter Newsletter 15(3) Fall; 3-4, 2017

和文著書
1. 井尾浩章、富野康日己: 透析用灌流用剤, ポケット判　治療薬UP-TO-DAT 2010、矢崎義雄、メディカルレビュー社、442-443、東京、2010　
2. 井尾浩章: 急性腎盂腎炎, 病気とけがの知識　腎臓尿路の病気、家庭医学大全科、髙久史麿、猿田享男、北村惣一郎、福井次矢（総合監修）、富野康日己（各編別監修）、法研、1958-1959、東京、2010
3. 井尾浩章、富野康日己: バスキュラーアクセスとは, , Q&A 透析ナーシング総合医学社；p18-19, 2011
4. 井尾浩章：腹膜透析関連腹膜炎　peritoneal dialysis (PD) related peritonitis, 今日の治療指針p549-550, ２０１２年版
5. 井尾浩章: 検査編　高血圧検査、治療編非薬物治療血液透析・腹膜透析疾患編全身疾患に伴う心血管異常腎不全（急性・慢性）, 循環器専門医研修テキスト P63-67, P111-113, P327-330, 2011
6. 井尾浩章: 透析・腎移植, 生活習慣病・腎臓病・高血圧対策Q&A100, p101-102, 2011
7. 井尾浩章: 「内科医のための薬の禁忌１００」腎不全患者に対する糖尿病治療薬やアルミニウム含有胃腸薬の投与,血液透析および腹膜透析患者に対しシタグリプチン（ジャヌビア、グラクティブ）などを投与してはならない, 慢性腎不全患者またはクレアチニンクリアランスが50ml/分以下の腎機能障害のある患者に対し、リバビリン（レベトール）を投与してはならない; 内科医のための薬の禁忌１００, p141-144, 2011
8. 井尾浩章: 動脈血O2分圧(PO2)、120　動脈血CO2分圧(PCO2), 臨床検査基準express, 2012
9. 井尾浩章: 低ナトリウム血症をきたしやすい降圧薬は何ですか？低ナトリウム血症の治療薬は何ですか？,腎性貧血に用いられる注射薬は何ですか？その効果と副作用は何ですか？また腎性貧血に鉄剤を用いてもいいですか？, 腎臓病・高血圧と薬剤　実践Q&A, p131-134, 2012
10. 井尾浩章: 腎機能検査の実際と臨床的意義1. 関連血液検査（臨床的意義）, 尿検査・腎機能検査の実際と臨床的意義, p108-130, 2013
11. 井尾浩章: .慢性腎臓病　e)急性腎不全, スマート栄養管理術100　－栄養管理が重要であるこれだけの理由, p137-141, 2013
12. 井尾浩章: 全身疾患による腎障害; アミロイド腎症、クリオグロブリン血症に伴う腎障害, Newエッセンシャル腎臓内科学, 2014
13. 井尾浩章；腹腔鏡：ぺリトネアルアクセスからカテーテル修復・抜去までLaparoscope is to use for only placement of peritoneal dialysis catheter but also reducing and drawing off in peritoneal dialysis patients. 実践インターベンショナルネフロロジー；インターベンショナルネフロロジー研究会、東京医学社、東京、p-、2016
14. 井尾浩章；超音波診断：バスキュラーアクセスの術前・術後評価Evaluation by ultrasound for pre and post-operative state of vascular access in hemodialysis patients. 実践インターベンショナルネフロロジー；インターベンショナルネフロロジー研究会、東京医学社、東京、p-、2016
15. 中田純一郎, 井尾浩章, 堀賢；国際基準から学ぶ透析医療の質・安全：感染管理の国際基準. 臨床透析、東京、32巻9号 1143-1150, 2016
16. 井尾浩章、編著：富野康日己；慢性腎臓病患者は歯槽骨の骨量が下がりやすいのはなぜ？；歯科医が押さえておきたい生活習慣病Q&A78、歯科総合出版社、東京、p- 2017
17. 井尾浩章、編著：富野康日己；成人における尿検査（各論）急性腎障害(AKI)の尿所見の特徴と診かた；『尿検査のみかた、考えかた』、中外医学社、東京、p-、2017
18. 井尾浩章、編著：富野康日己；クリオグロブリン血症・アミロイド腎：Newエッセンシャル腎臓内科学、医歯薬出版、東京、p-、2018
19. 井尾浩章、編著：富野康日己；シャント管理におけるフィラピー（FIRAPY）の有用性：血液透析患者さんのためのシャント管理とフットケアの新しい治療法－FIRAPYの効果―、広稜社、東京、p90-101、2018
20. 井尾浩章、編著：岡田一義・橋本寛文・水口　潤【総論】腹膜透析と適正体重；　腹膜透析診療指針、東京医学社、東京、39-42.2019

英文報告その他
1. Io Hiroaki: Experience of peritoneal dialysis (PD) catheter set up- Prevent PD patients from PD catheter’s complications – Taiwan Society of Nephrology: December 14, 2014
2. Sekiguchi Yoshimi, Hara kazuaki, Io Hiroaki, Nakano Takanori, Nakata Junichiro, Maeda Kunimi and Suzuki Yusuke；Laparoscopic evaluation of morphologic changes in the peritoneum of peritoneal dialysis patients；17th Congress of International Society of Peritoneal Dialysis May 5-8, 2018
3. Io Hiroaki, Sekiguchi Yoshimi, Nakano Takanori, Nakata Junichiro,Inoshita Hiroyuki, Ishizaka Masanori, Maeda Kunimi and Suzuki Yusuke；Predictive factors for maintaining residual renal function and associated factors for left ventricular hypertrophy with regards to a therapeutic strategy for a combination therapy with peritoneal dialysis and hemodialysis patients；17th Congress of International Society of Peritoneal Dialysis May 5-8, 2018
4. Maeda T, Io H, Hara K, Nakata J, Maiguma M, Ishizaka M, Sakumoto Y, Suzuki Y；Laparoscope is a useful tool for decannulation of a peritoneal dialysis cathter in peritoneal dialysis patient.；9th Asia Pacific Chapter Meeting of International Society for Peritoneal Dialysis (APCM-ISPD 2019)
5. Io H, Hara K, Wakabayashi K, Maeda T, Nakata J, Sekiguchi Y, Suzuki Y；Multicenter laparoscopic evaluation of peritoneal dialysis patients.；9th Asia Pacific Chapter Meeting of International Society for Peritoneal Dialysis (APCM-ISPD 2019)

和文報告その他
1. 井尾浩章: 日本透析医学会　【ワークショップ】;テーマ：透析導入患者の予後向上のための保存期からの取り組み;心血管合併症の危険因子である心筋重量指数(Left ventricular mass index: LVMI)と左房容積指数(Left atrium volume index: LAVi)の改善のために、『心エコー所見を活用する, 日本透析医学会学術集会総会　パシフィコ横浜　2011.6.18
2. 井尾浩章: 【シンポジウム】腹膜透析患者における腹腔鏡の有用性-トラブル時の対応-東京PD研究会 2012,5,12
3. 井尾浩章: 日本透析医学会　【ワークショップ】：日々対応する合併症; テーマ：慢性心不全への対策；心血管合併症の予防のために心筋重量指数(Left ventricular mass index: LVMI)に関わる因子を検討する, 日本透析医学会学術集会総会札幌 2012,6,24
4. 井尾浩章: 日本腹膜透析学会【ワークショップ】：「中性液の価値を問う：形態と機能へのインパクト」腹膜炎の既往なく腹膜透析6年の経過で計画離脱した症例の腹腔鏡所見, 日本腹膜透析学会大阪 2013,9,27
5. 井尾浩章: 日本腹膜透析学会腹膜病理検討会：「腹膜と血管」日本腹膜透析学会　山形 2014,9,6
6. 井尾浩章；【シンポジウム（指定）セッション】：CME2 腎臓専門医と腹膜透析；早期腹膜透析離脱原因と対策および腹膜透析離脱時期；第５９回日本腎臓学会学術集会・総会 2016.6.19
7. 井尾浩章；【シンポジウム（指定）セッション】：早期離脱；早期腹膜透析離脱原因と対策および腹膜透析離脱時期；第２２回日本腹膜透析医学会学術集会・総会 2016.9.24
8. 井尾浩章、原一彰、中田純一郎、神田怜生；【シンポジウム】セッション：PD離脱；早期腹膜透析離脱の原因と対策および腹膜透析離脱時期Causes and prevention strategies for early-stage drop-out and withdrawal times in peritoneal dialysis ；日本腹膜透析医学会 2016.9.24
9. 井尾浩章；【シンポジウム】「腹膜透析」最新の知見：早期腹膜透析離脱の原因と対策；第64回長野県透析研究会学術集会 2016.10.2
10. 井尾浩章；【ランチョンセミナー】：慢性腎臓病患者への貧血治療戦略－心血管イベント抑制へのstrategy－；第62回日本透析医学会学術集会・総会 2017.6.17
11. 井尾浩章、若林啓一、神田怜生、中田純一郎、鈴木祐介；透析クリニックスタッフのためのワークショップ「HD導入」：HD導入時のシャント管理：心機能とシャント血流を評価する；第26回腎不全外科研究会 2017.7.9
12. 井尾浩章：【教育セミナー4】 ES-04 出口部管理 up to date　第23回日本腹膜透析医学会学術集会・総会 2017.10.7
13. 若林啓一、井尾浩章、神田怜生、中田純一郎、鈴木祐介：【シンポジウム10】 PDHD併用療法 PDHD併用療法におけるシャント血流量と心機能への影響　第23回日本腹膜透析医学会学術集会・総会 2017.10.7
14. 井尾浩章、竜崎崇和、櫻田勉、寺脇博之、岡田一義、土谷健;【シンポジウム１】「PD人材育成システムの構築」:第24回日本腹膜透析医学会学術集会・総会 2018.10.8
15. 井尾浩章;【ランチョンセミナー】「慢性腎臓病(CKD)診療における病診連携の重要性」; 第48回日本腎臓学会東部学術大会2018.10.20
16. 井尾浩章、中田純一郎、鈴木祐介; 【シンポジウム】透析患者の心血管イベント発症に影響をおよぼす因子と心肥大・血圧測定時期の検討;第64回日本透析医学会学術集会・総会 2019.6.29
17. 井尾浩章: 【教育セミナー】慢性腎臓病（CKD）への治療戦略; ;第652回内科学会関東地方会 2019.7.14
18. 井尾浩章: 【教育講演１】PD導入期管理;第25回日本腹膜透析医学会学術集会・総会; 2019.1122
19. 井尾浩章【ランチョンセミナー】進化をつづけるPD療法;第25回日本腹膜透析医学会学術集会・総会; 2019.1122
20. 井尾浩章、塚田三佐緒、櫻田勉、寺脇博之、竜崎崇和、岡田一義、土谷健: 【シンポジウム５】　PD認定医制度のあらまし;第25回日本腹膜透析医学会学術集会・総会; 2019.1122

研究者

教育活動

ホームページURL

【学校法人順天堂】研究者情報データベース

研究業績詳細

井尾 浩章（イオ ヒロアキ）

井尾浩章（イオヒロアキ）